Metagenomi Therapeutics, Inc. (MGX) › Operating IncomeMetagenomi Therapeutics, Inc. (MGX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2023: -$78.49M2024: -$88.90M2025: -$96.01M-$96.01M2023Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$96.01M-8.0%2024-$88.90M-13.3%2023-$78.49M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share